FBRX
Forte Biosciences Inc
77.00$
+0.0%
vs. previous close
Closing price · As of: Aug 28, 2026
Statements
Cash Flow
Forte Biosciences Inc (FBRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -23 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.1 | -9.0 | -6.7 | -5.9 | -8.1 | -10 | -10 | -10 | -14 | -16 | -19 | -23 | -72 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 1.6 | 1.5 | 1.5 | 1.7 | 3.2 | -3.2 | 3.1 | |
| 0.2 | -3.9 | -0.1 | 5.8 | -0.6 | -3.4 | 3.9 | -0.3 | 2.2 | 5.6 | 0.1 | -2.0 | 5.9 | |
| 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 10 | – | 0.0 | – | – | -36 | 36 | – | -0.1 | – | – | -148 | – | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | 0.0 | – | – | – | |
| 25 | -0.1 | 0.0 | 0.0 | 0.0 | 52 | -2.3 | 70 | 1.3 | 0.0 | 0.1 | 162 | 163 | |
| 0.7 | -9.2 | -1.3 | -5.9 | -8.1 | 5.9 | 24 | 60 | -13 | -16 | -19 | -8.6 | -57 | |
| -9.1 | -9.0 | -6.7 | -5.9 | -8.1 | -10 | -10 | -10 | -14 | -16 | -19 | -23 | -72 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.